Professor Mehlen is the co-founder and Chief Executive Officer of NETRIS Pharma since Inception. As CEO, he has been instrumental in developing the Company from a Research-driven organization to a clinical stage biopharmaceutical company, currently conducting simultaneously multiple clinical trials. Patrick Mehlen is also the director of the Research Cancer Center of Lyon (France, CRCL), where he oversees the activities of more than 500 researchers conducting basic to translational research in oncology.

He has published over 170 peer-reviewed scientific publications and has received several awards including the silver medal from CNRS and the Pius XI Gold Medal from Pontificia Academia Scientiarum.

Professor Mehlen was elected EMBO member in 2006 and member of the National Academy of Sciences, Institut de France, in 2013.